OUR SCIENCE
We generate selective compounds leveraging
Our proprietary GENO-K™/GENO-D™ platform
Our Science
* Click on each image to view the original
GENO-D™
A Leading Platform for Innovative Targeted Protein Degradation Technology
GENO-D™ is Genosco’s next-generation research platform built on targeted protein degradation (TPD) technology.
By establishing a proprietary protein degrader library capable of degrading previously undruggable target proteins that could not be addressed by traditional small molecules, GENO-D™ aims to discover and develop innovative new drug candidates.
We are actively leveraging this platform to discover and develop targeted cancer therapeutics.
